Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.09 trillion and total revenue of $105.38 billion.
Market Cap
1.09T
Revenue
105.38B
Profits
-41.79B
PE Ratio
n/a
Profit Margin
-39.65%
Dividend Yield
0.04%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 116.41B | -2.49% | 1,671,798 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.67B | -1.09% | 975,576 | 14.34B |
| 3 | ARGX | argenx SE | 51.67B | -3.59% | 483,817 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.76B | -5.89% | 2,620,640 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 38.40B | -1.42% | 420,037 | 4.97B |
| 6 | INSM | Insmed Incorporated | 32.21B | -0.92% | 1,882,272 | 447.02M |
| 7 | BNTX | BioNTech SE | 26.48B | -2.97% | 683,063 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 25.46B | 0.96% | 6,011,639 | 2.35B |
| 9 | INCY | Incyte Corporation | 20.17B | 0.16% | 2,046,970 | 4.81B |
| 10 | GMAB | Genmab A/S | 19.33B | -2.92% | 1,519,662 | 3.85B |
| 11 | RVMD | Revolution Medicines, Inc. | 18.59B | -0.37% | 1,881,682 | - |
| 12 | MRNA | Moderna, Inc. | 15.97B | -4.44% | 11,662,755 | 2.23B |
| 13 | ROIV | Roivant Sciences Ltd. | 14.70B | -2.36% | 5,085,153 | 20.33M |
| 14 | IONS | Ionis Pharmaceuticals, Inc. | 13.52B | -1.78% | 2,951,813 | 966.96M |
| 15 | ASND | Ascendis Pharma A/S | 13.34B | -1.07% | 1,326,147 | 758.59M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 12.28B | -15.24% | 8,919,690 | 353.78M |
| 17 | EXEL | Exelixis, Inc. | 11.41B | -0.66% | 2,381,346 | 2.29B |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 10.98B | -0.82% | 1,252,890 | 3.09B |
| 19 | RNA | Avidity Biosciences, Inc. | 10.97B | 0.14% | 3,449,046 | 20.87M |
| 20 | SMMT | Summit Therapeutics Inc. | 10.68B | -3.95% | 3,837,631 | - |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.52B | -3.17% | 381,963 | 740.64M |
| 22 | TECH | Bio-Techne Corporation | 10.26B | -4.09% | 2,690,918 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 9.91B | -1.55% | 627,554 | 4.16B |
| 24 | HALO | Halozyme Therapeutics, Inc. | 9.22B | 0.63% | 2,631,444 | 1.24B |
| 25 | AXSM | Axsome Therapeutics, Inc. | 9.12B | -2.53% | 891,216 | 561.26M |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.05B | -5.02% | 3,242,096 | 829.45M |
| 27 | ABVX | ABIVAX Société Anonyme | 8.76B | -2.52% | 626,372 | 6.23M |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 8.48B | 0.75% | 623,286 | 7.46M |
| 29 | NUVL | Nuvalent, Inc. | 7.84B | -3.90% | 531,308 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 7.76B | -0.55% | 284,674 | 373.16M |
| 31 | PCVX | Vaxcyte, Inc. | 7.74B | -2.48% | 1,842,320 | - |
| 32 | CYTK | Cytokinetics, Incorporated | 7.37B | -5.16% | 2,071,727 | 87.21M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.93B | -3.80% | 639,565 | 174.33M |
| 34 | BLTE | Belite Bio, Inc | 6.69B | -2.44% | 327,393 | - |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.08B | -2.27% | 1,428,107 | 43.74M |
| 36 | CAI | Caris Life Sciences, Inc. | 6.00B | -2.70% | 3,701,573 | 649.06M |
| 37 | MIRM | Mirum Pharmaceuticals, Inc. | 5.88B | -5.51% | 667,150 | 471.79M |
| 38 | PTCT | PTC Therapeutics, Inc. | 5.81B | -2.10% | 1,326,372 | 1.78B |
| 39 | IBRX | ImmunityBio, Inc. | 5.56B | -4.08% | 18,369,502 | 82.56M |
| 40 | COGT | Cogent Biosciences, Inc. | 5.43B | -3.12% | 1,395,183 | - |
| 41 | GPCR | Structure Therapeutics Inc. | 5.06B | -9.91% | 2,150,191 | - |
| 42 | PTGX | Protagonist Therapeutics, Inc. | 5.04B | -3.16% | 457,064 | 209.22M |
| 43 | IMVT | Immunovant, Inc. | 4.88B | -4.33% | 2,087,365 | - |
| 44 | CELC | Celcuity Inc. | 4.83B | -3.08% | 896,477 | - |
| 45 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.59B | -5.57% | 1,043,901 | 1.54M |
| 46 | SRRK | Scholar Rock Holding Corporation | 4.53B | -5.08% | 891,969 | - |
| 47 | FOLD | Amicus Therapeutics, Inc. | 4.48B | 0.07% | 4,435,497 | 598.70M |
| 48 | CRSP | CRISPR Therapeutics AG | 4.37B | -8.55% | 2,624,236 | 38.34M |
| 49 | APGE | Apogee Therapeutics, Inc. | 4.19B | -4.24% | 708,896 | - |
| 50 | TGTX | TG Therapeutics, Inc. | 4.06B | -4.67% | 2,568,424 | 531.90M |
| 51 | CORT | Corcept Therapeutics Incorporated | 4.04B | -4.41% | 1,063,375 | 741.17M |
| 52 | ACAD | ACADIA Pharmaceuticals Inc. | 3.97B | -3.18% | 1,184,411 | 1.05B |
| 53 | CGON | CG Oncology, Inc. | 3.97B | -5.35% | 1,080,810 | 2.17M |
| 54 | ACLX | Arcellx, Inc. | 3.87B | -3.65% | 1,066,246 | 35.90M |
| 55 | TERN | Terns Pharmaceuticals, Inc. | 3.84B | -2.00% | 1,575,124 | - |
| 56 | ADMA | ADMA Biologics, Inc. | 3.79B | -3.34% | 2,045,458 | 488.56M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 3.77B | -3.35% | 218,909 | 251.23M |
| 58 | ERAS | Erasca, Inc. | 3.68B | 5.69% | 6,010,138 | - |
| 59 | NAMS | NewAmsterdam Pharma Company N.V. | 3.64B | -2.79% | 1,382,585 | 35.24M |
| 60 | LQDA | Liquidia Corporation | 3.62B | -6.46% | 1,436,538 | 69.22M |
| 61 | CNTA | Centessa Pharmaceuticals plc | 3.44B | -5.84% | 3,975,716 | 15.00M |
| 62 | ALMS | Alumis Inc. | 3.28B | -0.04% | 989,741 | 22.12M |
| 63 | ARQT | Arcutis Biotherapeutics, Inc. | 3.19B | -0.04% | 1,538,487 | 317.93M |
| 64 | DNLI | Denali Therapeutics Inc. | 3.13B | -5.92% | 1,626,815 | - |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.12B | -1.85% | 542,291 | 7.50M |
| 66 | LEGN | Legend Biotech Corporation | 3.08B | 0.30% | 3,342,059 | 909.05M |
| 67 | VKTX | Viking Therapeutics, Inc. | 2.97B | -11.06% | 5,770,654 | - |
| 68 | IRON | Disc Medicine, Inc. | 2.96B | -4.07% | 607,278 | - |
| 69 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.94B | -4.59% | 1,255,548 | 578.20M |
| 70 | VERA | Vera Therapeutics, Inc. | 2.91B | -4.19% | 1,197,610 | - |
| 71 | EWTX | Edgewise Therapeutics, Inc. | 2.88B | -4.50% | 836,413 | - |
| 72 | APLS | Apellis Pharmaceuticals, Inc. | 2.85B | -2.55% | 2,942,931 | 1.02B |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 2.78B | -4.60% | 643,335 | 214.83M |
| 74 | VRDN | Viridian Therapeutics, Inc. | 2.78B | -4.02% | 1,670,083 | 70.79M |
| 75 | DYN | Dyne Therapeutics, Inc. | 2.72B | -9.22% | 2,169,664 | - |
| 76 | IMNM | Immunome, Inc. | 2.65B | -9.13% | 1,489,275 | 9.68M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.64B | -6.98% | 1,792,746 | 435.83M |
| 78 | TARS | Tarsus Pharmaceuticals, Inc. | 2.63B | -2.39% | 605,245 | 366.10M |
| 79 | SYRE | Spyre Therapeutics, Inc. | 2.56B | 2.71% | 972,452 | - |
| 80 | ADPT | Adaptive Biotechnologies Corporation | 2.51B | -4.80% | 2,497,138 | 252.75M |
| 81 | RCUS | Arcus Biosciences, Inc. | 2.48B | -4.57% | 923,361 | 240.00M |
| 82 | BEAM | Beam Therapeutics Inc. | 2.44B | -8.24% | 2,003,738 | 55.70M |
| 83 | TLX | Telix Pharmaceuticals Limited | 2.39B | -2.38% | 167,389 | 664.23M |
| 84 | WVE | Wave Life Sciences Ltd. | 2.33B | -4.35% | 2,933,217 | 109.23M |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.29B | -3.65% | 1,719,839 | 630.60M |
| 86 | AAPG | Ascentage Pharma Group International | 2.23B | -2.19% | 1,478 | 54.52M |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 2.23B | -7.87% | 1,177,869 | - |
| 88 | GLPG | Galapagos NV | 2.22B | -3.61% | 76,744 | 336.64M |
| 89 | MESO | Mesoblast Limited | 2.15B | -5.36% | 291,728 | 17.20M |
| 90 | SLNO | Soleno Therapeutics, Inc. | 2.13B | -6.03% | 1,231,240 | 98.68M |
| 91 | MAZE | Maze Therapeutics, Inc. | 2.11B | -8.70% | 953,439 | 2.50M |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 2.10B | -2.44% | 378,844 | 825.94M |
| 93 | DNTH | Dianthus Therapeutics, Inc. | 2.01B | -3.26% | 951,689 | 3.08M |
| 94 | OLMA | Olema Pharmaceuticals, Inc. | 1.97B | -5.05% | 1,115,176 | - |
| 95 | NUVB | Nuvation Bio Inc. | 1.93B | -4.10% | 6,110,387 | 26.75M |
| 96 | OCUL | Ocular Therapeutix, Inc. | 1.90B | 4.21% | 8,943,620 | 51.95M |
| 97 | ZLAB | Zai Lab Limited | 1.89B | -0.12% | 822,718 | 441.63M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 1.88B | -2.19% | 890,486 | 265.81M |
| 99 | RXRX | Recursion Pharmaceuticals, Inc. | 1.85B | -8.72% | 40,524,296 | 43.69M |
| 100 | VCEL | Vericel Corporation | 1.79B | -4.07% | 431,085 | 258.72M |
| 101 | SRPT | Sarepta Therapeutics, Inc. | 1.78B | -13.68% | 6,009,518 | 2.41B |
| 102 | RAPT | RAPT Therapeutics, Inc. | 1.78B | -0.17% | 11,024,519 | - |
| 103 | SNDX | Syndax Pharmaceuticals, Inc. | 1.75B | -1.37% | 1,667,672 | 111.30M |
| 104 | STOK | Stoke Therapeutics, Inc. | 1.74B | -4.75% | 712,810 | 205.63M |
| 105 | ARDX | Ardelyx, Inc. | 1.70B | -5.15% | 5,420,871 | 398.23M |
| 106 | MNKD | MannKind Corporation | 1.69B | -4.67% | 3,208,301 | 313.79M |
| 107 | ZYME | Zymeworks Inc. | 1.65B | -4.72% | 619,066 | 134.48M |
| 108 | NRIX | Nurix Therapeutics, Inc. | 1.64B | -3.63% | 1,119,748 | 83.98M |
| 109 | PHVS | Pharvaris N.V. | 1.63B | -5.28% | 189,800 | - |
| 110 | MBX | MBX Biosciences, Inc. | 1.62B | -6.05% | 487,309 | - |
| 111 | INVA | Innoviva, Inc. | 1.61B | 0.42% | 717,339 | 388.52M |
| 112 | TNGX | Tango Therapeutics, Inc. | 1.61B | -3.00% | 2,335,876 | 66.50M |
| 113 | ELVN | Enliven Therapeutics, Inc. | 1.60B | -2.98% | 948,806 | - |
| 114 | DFTX | Definium Therapeutics, Inc. | 1.60B | -4.58% | 1,710,476 | - |
| 115 | CRVS | Corvus Pharmaceuticals, Inc. | 1.60B | -8.45% | 1,916,910 | - |
| 116 | OCS | Oculis Holding AG | 1.59B | 4.25% | 264,495 | 992.00K |
| 117 | SION | Sionna Therapeutics, Inc. | 1.57B | -14.68% | 562,991 | - |
| 118 | TYRA | Tyra Biosciences, Inc. | 1.57B | -4.26% | 625,542 | - |
| 119 | IMCR | Immunocore Holdings plc | 1.56B | -1.84% | 1,143,167 | 379.59M |
| 120 | AGIO | Agios Pharmaceuticals, Inc. | 1.55B | -4.08% | 1,107,611 | 44.79M |
| 121 | QURE | uniQure N.V. | 1.53B | -7.99% | 1,642,911 | 15.75M |
| 122 | ORKA | Oruka Therapeutics, Inc. | 1.52B | -4.73% | 345,632 | - |
| 123 | CLDX | Celldex Therapeutics, Inc. | 1.50B | -6.96% | 1,218,266 | 2.60M |
| 124 | PGEN | Precigen, Inc. | 1.50B | -7.02% | 3,727,197 | 6.31M |
| 125 | GLUE | Monte Rosa Therapeutics, Inc. | 1.50B | -3.23% | 1,300,819 | 181.54M |
| 126 | BHVN | Biohaven Ltd. | 1.43B | -2.09% | 3,958,797 | - |
| 127 | RLAY | Relay Therapeutics, Inc. | 1.41B | -4.00% | 2,615,288 | 8.36M |
| 128 | UPB | Upstream Bio, Inc. | 1.41B | -11.50% | 619,271 | 2.80M |
| 129 | TRVI | Trevi Therapeutics, Inc. | 1.40B | -4.45% | 1,678,012 | - |
| 130 | DBVT | DBV Technologies S.A. | 1.34B | -8.33% | 425,177 | 5.50M |
| 131 | ANAB | AnaptysBio, Inc. | 1.33B | -0.99% | 594,885 | 169.47M |
| 132 | MANE | Veradermics, Incorporated | 1.30B | -1.56% | 934,640 | - |
| 133 | KOD | Kodiak Sciences Inc. | 1.30B | -6.12% | 583,947 | - |
| 134 | NTLA | Intellia Therapeutics, Inc. | 1.28B | -10.28% | 5,856,350 | 57.53M |
| 135 | NVAX | Novavax, Inc. | 1.28B | -4.84% | 4,150,296 | 1.06B |
| 136 | FTRE | Fortrea Holdings Inc. | 1.28B | -14.07% | 3,170,461 | 2.76B |
| 137 | SVRA | Savara Inc. | 1.27B | -3.73% | 1,573,312 | - |
| 138 | ATAI | AtaiBeckley Inc. | 1.24B | -5.54% | 5,838,123 | 3.02M |
| 139 | RAPP | Rapport Therapeutics, Inc. | 1.22B | -3.35% | 338,270 | - |
| 140 | TSHA | Taysha Gene Therapies, Inc. | 1.21B | -2.86% | 3,936,440 | 6.31M |
| 141 | CAPR | Capricor Therapeutics, Inc. | 1.19B | -6.00% | 1,202,480 | 11.13M |
| 142 | INBX | Inhibrx Biosciences, Inc. | 1.19B | -1.25% | 148,812 | 1.40M |
| 143 | IMTX | Immatics N.V. | 1.15B | -8.24% | 408,894 | 99.45M |
| 144 | IVA | Inventiva S.A. | 1.15B | -2.52% | 276,163 | 19.93M |
| 145 | XERS | Xeris Biopharma Holdings, Inc. | 1.15B | -2.40% | 1,357,312 | 266.14M |
| 146 | PHAR | Pharming Group N.V. | 1.13B | -4.98% | 67,186 | 362.27M |
| 147 | ZBIO | Zenas BioPharma, Inc. | 1.13B | 1.69% | 941,352 | 15.00M |
| 148 | CMPX | Compass Therapeutics, Inc. | 1.11B | -1.74% | 2,170,236 | 850.00K |
| 149 | SEPN | Septerna, Inc. | 1.10B | -1.72% | 385,601 | 22.05M |
| 150 | DAWN | Day One Biopharmaceuticals, Inc. | 1.08B | -2.42% | 2,695,556 | 133.67M |
| 151 | MLTX | MoonLake Immunotherapeutics | 1.05B | -1.73% | 1,381,236 | - |
| 152 | EYPT | EyePoint, Inc. | 1.05B | 3.24% | 1,619,689 | 42.34M |
| 153 | NBTX | Nanobiotix S.A. | 1.03B | -3.22% | 4,826 | 11.93M |
| 154 | AKTS | Aktis Oncology, Inc. | 1.03B | -1.76% | 197,092 | 5.56M |
| 155 | VTYX | Ventyx Biosciences, Inc. | 1.00B | 0.22% | 2,260,612 | - |
| 156 | TBPH | Theravance Biopharma, Inc. | 992.17M | -2.54% | 351,660 | 80.33M |
| 157 | PHAT | Phathom Pharmaceuticals, Inc. | 971.64M | -6.20% | 1,226,642 | 147.19M |
| 158 | ORIC | ORIC Pharmaceuticals, Inc. | 970.00M | -6.13% | 1,472,059 | - |
| 159 | VIR | Vir Biotechnology, Inc. | 962.75M | -7.73% | 1,268,274 | 16.86M |
| 160 | URGN | UroGen Pharma Ltd. | 960.05M | -0.97% | 1,029,020 | 96.52M |
| 161 | SPRY | ARS Pharmaceuticals, Inc. | 955.87M | -4.64% | 1,141,483 | 142.77M |
| 162 | SANA | Sana Biotechnology, Inc. | 945.60M | -12.78% | 3,595,504 | - |
| 163 | IOVA | Iovance Biotherapeutics, Inc. | 936.84M | -3.28% | 15,714,342 | 250.43M |
| 164 | GERN | Geron Corporation | 932.00M | -0.68% | 15,485,923 | 183.40M |
| 165 | PVLA | Palvella Therapeutics, Inc. | 905.96M | -6.80% | 286,307 | - |
| 166 | CTMX | CytomX Therapeutics, Inc. | 887.84M | -7.58% | 2,761,497 | 113.63M |
| 167 | AVBP | ArriVent BioPharma, Inc. | 881.36M | -3.09% | 814,687 | - |
| 168 | GHRS | GH Research PLC | 847.32M | -12.10% | 499,623 | - |
| 169 | ANNX | Annexon, Inc. | 839.18M | -6.79% | 2,383,753 | - |
| 170 | VALN | Valneva SE | 834.26M | -2.41% | 12,613 | 211.09M |
| 171 | ARVN | Arvinas, Inc. | 832.35M | -3.21% | 650,610 | 312.30M |
| 172 | ABCL | AbCellera Biologics Inc. | 832.15M | -14.98% | 11,070,707 | 35.33M |
| 173 | BCAX | Bicara Therapeutics Inc. | 826.11M | -7.88% | 461,326 | - |
| 174 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 811.89M | -13.17% | 469,097 | - |
| 175 | EIKN | Eikon Therapeutics, Inc. | 809.77M | -16.67% | 4,900,577 | - |
| 176 | MRVI | Maravai LifeSciences Holdings, Inc. | 790.13M | -5.50% | 1,725,284 | 192.44M |
| 177 | XNCR | Xencor, Inc. | 772.66M | -6.16% | 487,559 | 150.13M |
| 178 | OMER | Omeros Corporation | 761.47M | -6.69% | 1,815,988 | - |
| 179 | PLYX | Polaryx Therapeutics, Inc. | 757.49M | -28.89% | 16,528 | - |
| 180 | YDES | YD Bio Limited | 756.64M | -3.32% | 38,054 | 510.36K |
| 181 | MDXG | MiMedx Group, Inc. | 744.95M | -1.57% | 1,826,516 | 393.44M |
| 182 | DRUG | Bright Minds Biosciences Inc. | 735.11M | -3.84% | 128,840 | - |
| 183 | JANX | Janux Therapeutics, Inc. | 732.60M | -8.63% | 1,521,305 | 10.00M |
| 184 | KALV | KalVista Pharmaceuticals, Inc. | 727.61M | -3.91% | 751,564 | 1.43M |
| 185 | NKTR | Nektar Therapeutics | 714.40M | -6.70% | 723,804 | 62.60M |
| 186 | ABUS | Arbutus Biopharma Corporation | 705.83M | -5.41% | 1,607,019 | 14.61M |
| 187 | CGEM | Cullinan Therapeutics, Inc. | 700.05M | -3.89% | 771,789 | - |
| 188 | MPLT | MapLight Therapeutics, Inc. | 685.17M | -6.55% | 211,066 | - |
| 189 | GYRE | Gyre Therapeutics, Inc. | 682.59M | -3.35% | 46,509 | 107.27M |
| 190 | JBIO | Jade Biosciences, Inc. | 662.00M | -10.06% | 277,556 | - |
| 191 | KURA | Kura Oncology, Inc. | 643.93M | -8.30% | 1,715,024 | 104.03M |
| 192 | FULC | Fulcrum Therapeutics, Inc. | 629.36M | -3.64% | 447,225 | 80.00M |
| 193 | ALT | Altimmune, Inc. | 616.14M | -4.09% | 3,960,359 | 20.00K |
| 194 | LBRX | LB Pharmaceuticals Inc | 603.64M | 12.71% | 413,717 | - |
| 195 | RIGL | Rigel Pharmaceuticals, Inc. | 602.99M | -4.95% | 421,678 | 282.08M |
| 196 | SLS | SELLAS Life Sciences Group, Inc. | 601.10M | -7.59% | 6,806,949 | - |
| 197 | ENGN | enGene Holdings Inc. | 593.48M | -7.61% | 1,157,388 | - |
| 198 | DRTS | Alpha Tau Medical Ltd. | 584.91M | -9.74% | 358,199 | - |
| 199 | MGTX | MeiraGTx Holdings plc | 579.53M | -7.46% | 473,335 | 27.42M |
| 200 | CRMD | CorMedix Inc. | 579.10M | -6.25% | 1,820,677 | 214.30M |
| 201 | PRME | Prime Medicine, Inc. | 573.60M | -6.76% | 4,518,469 | 5.98M |
| 202 | REPL | Replimune Group, Inc. | 572.23M | -1.00% | 1,666,781 | - |
| 203 | DSGN | Design Therapeutics, Inc. | 566.79M | -0.50% | 272,441 | - |
| 204 | GOSS | Gossamer Bio, Inc. | 563.60M | -1.02% | 5,107,115 | 44.05M |
| 205 | CTNM | Contineum Therapeutics, Inc. | 528.95M | -2.16% | 248,791 | - |
| 206 | KROS | Keros Therapeutics, Inc. | 525.24M | -4.49% | 268,113 | 246.72M |
| 207 | EVMN | Evommune, Inc. | 525.19M | -12.04% | 208,604 | 13.00M |
| 208 | PROK | ProKidney Corp. | 520.44M | -8.95% | 1,473,173 | 744.00K |
| 209 | RGNX | REGENXBIO Inc. | 519.39M | -4.56% | 958,807 | 161.32M |
| 210 | FBRX | Forte Biosciences, Inc. | 513.72M | -10.08% | 197,381 | - |
| 211 | LXEO | Lexeo Therapeutics, Inc. | 502.88M | -5.23% | 1,211,173 | - |
| 212 | TENX | Tenax Therapeutics, Inc. | 501.45M | -5.86% | 237,176 | - |
| 213 | VOR | Vor Biopharma Inc. | 501.14M | -2.66% | 1,105,143 | - |
| 214 | LXRX | Lexicon Pharmaceuticals, Inc. | 493.08M | -7.09% | 6,857,835 | 70.86M |
| 215 | SLDB | Solid Biosciences Inc. | 485.38M | -4.45% | 1,450,711 | - |
| 216 | VSTM | Verastem, Inc. | 484.70M | -7.51% | 1,843,180 | 13.38M |
| 217 | ADCT | ADC Therapeutics SA | 484.36M | -4.40% | 741,226 | 75.21M |
| 218 | IVVD | Invivyd, Inc. | 482.20M | -7.07% | 3,332,803 | 50.04M |
| 219 | LYEL | Lyell Immunopharma, Inc. | 480.96M | -6.37% | 104,200 | 41.00K |
| 220 | DNA | Ginkgo Bioworks Holdings, Inc. | 472.88M | 0.60% | 4,547,996 | 180.61M |
| 221 | ZVRA | Zevra Therapeutics, Inc. | 470.65M | -6.49% | 775,437 | 84.39M |
| 222 | PRTA | Prothena Corporation plc | 449.48M | -6.07% | 518,923 | 11.79M |
| 223 | EPRX | Eupraxia Pharmaceuticals Inc. | 444.78M | -3.75% | 164,519 | - |
| 224 | ANRO | Alto Neuroscience, Inc. | 438.35M | -5.93% | 319,711 | - |
| 225 | LENZ | LENZ Therapeutics, Inc. | 437.12M | -4.45% | 863,693 | 17.50M |
| 226 | OCGN | Ocugen, Inc. | 436.09M | -5.67% | 4,440,296 | 5.37M |
| 227 | FDMT | 4D Molecular Therapeutics, Inc. | 427.96M | -9.69% | 1,177,289 | 120.00K |
| 228 | TECX | Tectonic Therapeutic, Inc. | 427.85M | -1.55% | 794,334 | - |
| 229 | VNDA | Vanda Pharmaceuticals Inc. | 427.27M | -4.87% | 1,361,560 | 212.07M |
| 230 | PRTC | PureTech Health plc | 419.49M | -2.22% | 430 | 6.39M |
| 231 | ZURA | Zura Bio Limited | 417.77M | -5.66% | 276,727 | - |
| 232 | KYTX | Kyverna Therapeutics, Inc. | 415.33M | -4.59% | 718,366 | - |
| 233 | NAGE | Niagen Bioscience, Inc. | 410.86M | -7.32% | 1,241,990 | 124.71M |
| 234 | LCTX | Lineage Cell Therapeutics, Inc. | 407.11M | -3.45% | 1,261,897 | 10.82M |
| 235 | DMAC | DiaMedica Therapeutics Inc. | 403.98M | -4.56% | 145,500 | - |
| 236 | ASMB | Assembly Biosciences, Inc. | 401.60M | -6.14% | 98,777 | 37.19M |
| 237 | BNTC | Benitec Biopharma Inc. | 399.07M | -6.12% | 118,261 | - |
| 238 | IMMP | Immutep Limited | 390.06M | -2.96% | 110,201 | 3.31M |
| 239 | VTVT | vTv Therapeutics Inc. | 384.80M | -14.83% | 35,589 | 17.00K |
| 240 | NBP | NovaBridge Biosciences | 383.92M | -2.63% | 455,996 | - |
| 241 | ABSI | Absci Corporation | 380.44M | -13.06% | 6,645,542 | 2.82M |
| 242 | MNPR | Monopar Therapeutics Inc. | 380.11M | -4.29% | 287,481 | - |
| 243 | ENTA | Enanta Pharmaceuticals, Inc. | 376.37M | -3.78% | 176,569 | 65.32M |
| 244 | ANL | Adlai Nortye Ltd. | 374.17M | 0.60% | 530,908 | -1.35M |
| 245 | BCYC | Bicycle Therapeutics plc | 368.34M | -7.17% | 525,765 | 28.34M |
| 246 | ACRS | Aclaris Therapeutics, Inc. | 367.29M | -4.24% | 720,222 | 15.74M |
| 247 | ALLO | Allogene Therapeutics, Inc. | 366.31M | -9.44% | 4,062,911 | 22.00K |
| 248 | TRDA | Entrada Therapeutics, Inc. | 360.41M | -7.12% | 366,031 | 61.52M |
| 249 | AUTL | Autolus Therapeutics plc | 351.31M | -4.35% | 2,034,426 | 51.13M |
| 250 | GLSI | Greenwich LifeSciences, Inc. | 349.00M | -6.74% | 304,048 | - |
| 251 | TARA | Protara Therapeutics, Inc. | 348.32M | -3.13% | 708,062 | - |
| 252 | PBYI | Puma Biotechnology, Inc. | 342.16M | -4.37% | 433,704 | 212.00M |
| 253 | AVXL | Anavex Life Sciences Corp. | 340.42M | -7.75% | 1,438,474 | - |
| 254 | AURA | Aura Biosciences, Inc. | 340.38M | -6.78% | 189,837 | - |
| 255 | NMRA | Neumora Therapeutics, Inc. | 333.08M | -2.97% | 796,790 | - |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 324.67M | -9.91% | 3,054,189 | - |
| 257 | XFOR | X4 Pharmaceuticals, Inc. | 320.02M | -4.94% | 621,836 | 33.98M |
| 258 | AVIR | Atea Pharmaceuticals, Inc. | 314.07M | -1.95% | 513,507 | - |
| 259 | IMMX | Immix Biopharma, Inc. | 313.54M | -2.78% | 795,813 | - |
| 260 | XOMA | XOMA Royalty Corporation | 308.59M | -7.40% | 197,119 | 47.11M |
| 261 | FHTX | Foghorn Therapeutics Inc. | 306.38M | -7.10% | 233,743 | 24.52M |
| 262 | ALDX | Aldeyra Therapeutics, Inc. | 306.23M | -2.49% | 605,210 | - |
| 263 | PEPG | PepGen Inc. | 294.93M | -12.63% | 1,326,582 | - |
| 264 | ARMP | Armata Pharmaceuticals, Inc. | 294.17M | -0.25% | 36,023 | 5.05M |
| 265 | ACIU | AC Immune SA | 292.87M | -3.27% | 419,148 | 5.48M |
| 266 | HELP | Cybin Inc. | 292.44M | -7.86% | 810,414 | - |
| 267 | IMRX | Immuneering Corporation | 291.86M | -4.64% | 1,267,204 | - |
| 268 | CADL | Candel Therapeutics, Inc. | 290.41M | -7.36% | 739,811 | - |
| 269 | ENLV | Enlivex Therapeutics Ltd. | 275.36M | 5.45% | 1,220,324 | - |
| 270 | RZLT | Rezolute, Inc. | 270.76M | 0.34% | 3,261,511 | - |
| 271 | CLLS | Cellectis S.A. | 269.06M | -1.13% | 87,265 | 82.55M |
| 272 | ABEO | Abeona Therapeutics Inc. | 265.54M | -3.54% | 1,249,732 | 400.00K |
| 273 | RLMD | Relmada Therapeutics, Inc. | 264.00M | -1.37% | 580,615 | - |
| 274 | LRMR | Larimar Therapeutics, Inc. | 262.76M | -6.40% | 1,502,022 | - |
| 275 | FENC | Fennec Pharmaceuticals Inc. | 261.62M | -3.53% | 113,286 | 38.79M |
| 276 | NAUT | Nautilus Biotechnology, Inc. | 255.14M | -2.88% | 166,783 | - |
| 277 | NGNE | Neurogene Inc. | 253.57M | -4.71% | 213,692 | 925.00K |
| 278 | CHRS | Coherus Oncology, Inc. | 252.62M | -5.86% | 1,692,428 | 277.73M |
| 279 | AARD | Aardvark Therapeutics, Inc. | 245.82M | -10.11% | 183,526 | - |
| 280 | AVTX | Avalo Therapeutics, Inc. | 243.44M | -8.49% | 308,271 | 192.00K |
| 281 | OABI | OmniAb, Inc. | 237.53M | -5.17% | 503,753 | 21.09M |
| 282 | PLX | Protalix BioTherapeutics, Inc. | 234.03M | 0.34% | 2,424,933 | 61.84M |
| 283 | STTK | Shattuck Labs, Inc. | 225.91M | -7.27% | 495,044 | 1.00M |
| 284 | CABA | Cabaletta Bio, Inc. | 224.30M | -7.17% | 2,658,043 | - |
| 285 | PALI | Palisade Bio, Inc. | 223.50M | -5.06% | 5,758,815 | - |
| 286 | CLYM | Climb Bio, Inc. | 222.01M | -7.92% | 362,135 | - |
| 287 | HRTX | Heron Therapeutics, Inc. | 221.87M | -8.33% | 984,885 | 155.10M |
| 288 | MDWD | MediWound Ltd. | 220.72M | -2.30% | 72,239 | 20.93M |
| 289 | NVCT | Nuvectis Pharma, Inc. | 216.45M | -0.12% | 73,340 | - |
| 290 | IKT | Inhibikase Therapeutics, Inc. | 216.12M | 1.28% | 865,153 | 1.00 |
| 291 | SLN | Silence Therapeutics plc | 213.50M | 5.12% | 279,884 | 25.83M |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 210.61M | -1.84% | 211,302 | 2.82M |
| 293 | ACHV | Achieve Life Sciences, Inc. | 210.27M | -6.40% | 765,544 | - |
| 294 | CNTX | Context Therapeutics Inc. | 207.65M | -1.74% | 1,424,468 | - |
| 295 | ALEC | Alector, Inc. | 201.38M | -4.40% | 1,665,777 | 69.05M |
| 296 | ARCT | Arcturus Therapeutics Holdings Inc. | 199.47M | -4.23% | 491,476 | 97.60M |
| 297 | VYGR | Voyager Therapeutics, Inc. | 196.82M | -5.35% | 872,933 | 31.32M |
| 298 | SABS | SAB Biotherapeutics, Inc. | 189.48M | -5.91% | 290,028 | 114.70K |
| 299 | OVID | Ovid Therapeutics Inc. | 188.77M | -2.03% | 1,488,591 | 6.61M |
| 300 | CAMP | Camp4 Therapeutics Corporation | 186.25M | 1.41% | 48,527 | 3.80M |
| 301 | TNXP | Tonix Pharmaceuticals Holding Corp. | 185.25M | -7.94% | 426,959 | 10.30M |
| 302 | CBIO | Crescent Biopharma, Inc. | 183.96M | -3.09% | 388,618 | - |
| 303 | GALT | Galectin Therapeutics Inc. | 183.26M | -3.97% | 221,367 | - |
| 304 | NERV | Minerva Neurosciences, Inc. | 182.62M | -9.64% | 105,476 | - |
| 305 | SRZN | Surrozen, Inc. | 182.14M | -10.15% | 237,809 | 3.60M |
| 306 | SLGL | Sol-Gel Technologies Ltd. | 180.24M | -1.90% | 15,708 | 18.97M |
| 307 | NTHI | NeOnc Technologies Holdings, Inc. | 179.94M | -4.84% | 86,647 | 59.99K |
| 308 | IRD | Opus Genetics, Inc. | 177.93M | 12.66% | 2,628,154 | 14.63M |
| 309 | SGMT | Sagimet Biosciences Inc. | 176.92M | -10.53% | 719,413 | - |
| 310 | MIST | Milestone Pharmaceuticals Inc. | 174.72M | -8.02% | 2,928,713 | - |
| 311 | MOLN | Molecular Partners AG | 171.40M | 4.77% | 11,103 | 856.30K |
| 312 | HUMA | Humacyte, Inc. | 171.03M | -7.51% | 4,068,742 | 1.57M |
| 313 | PRLD | Prelude Therapeutics Incorporated | 166.44M | -12.17% | 350,725 | 10.50M |
| 314 | CCCC | C4 Therapeutics, Inc. | 165.72M | -9.52% | 852,112 | 30.11M |
| 315 | IPHA | Innate Pharma S.A. | 164.84M | 0.56% | 4,205 | 14.84M |
| 316 | RNAC | Cartesian Therapeutics, Inc. | 163.30M | -8.19% | 154,934 | 1.09M |
| 317 | EDIT | Editas Medicine, Inc. | 162.54M | -14.62% | 2,214,356 | 46.38M |
| 318 | TNYA | Tenaya Therapeutics, Inc. | 162.38M | -10.94% | 3,197,250 | - |
| 319 | TLSA | Tiziana Life Sciences Ltd | 162.08M | -7.97% | 203,968 | - |
| 320 | ELDN | Eledon Pharmaceuticals, Inc. | 156.32M | -8.37% | 421,541 | - |
| 321 | KLRS | Kalaris Therapeutics, Inc. | 156.17M | -5.44% | 39,234 | - |
| 322 | THAR | Tharimmune, Inc. | 155.35M | -16.91% | 1,363,963 | - |
| 323 | PRQR | ProQR Therapeutics N.V. | 153.80M | -5.81% | 294,770 | 18.86M |
| 324 | CBUS | Cibus, Inc. | 151.33M | -2.61% | 354,170 | 3.79M |
| 325 | VXRT | Vaxart, Inc. | 148.81M | -1.24% | - | 148.20M |
| 326 | CGEN | Compugen Ltd. | 148.72M | -8.62% | 450,880 | 6.90M |
| 327 | IPSC | Century Therapeutics, Inc. | 145.97M | -6.70% | 947,915 | 113.34M |
| 328 | ZNTL | Zentalis Pharmaceuticals, Inc. | 143.10M | -13.33% | 717,282 | 26.87M |
| 329 | CRBU | Caribou Biosciences, Inc. | 138.33M | -8.64% | 1,257,252 | 9.30M |
| 330 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 136.93M | -7.74% | 222,061 | - |
| 331 | NKTX | Nkarta, Inc. | 136.38M | -6.34% | 1,059,447 | - |
| 332 | ABOS | Acumen Pharmaceuticals, Inc. | 136.29M | -8.16% | 609,369 | - |
| 333 | RANI | Rani Therapeutics Holdings, Inc. | 133.67M | -7.56% | 1,835,131 | 1.20M |
| 334 | UNCY | Unicycive Therapeutics, Inc. | 133.03M | -4.92% | 588,469 | - |
| 335 | ELTX | Elicio Therapeutics, Inc. | 132.99M | -3.06% | 130,017 | - |
| 336 | SGMO | Sangamo Therapeutics, Inc. | 131.39M | -1.86% | 8,926,293 | 32.88M |
| 337 | SPRO | Spero Therapeutics, Inc. | 129.30M | 0.22% | 746,954 | 40.55M |
| 338 | ORMP | Oramed Pharmaceuticals Inc. | 128.96M | -5.26% | 209,337 | 2.00M |
| 339 | CNTB | Connect Biopharma Holdings Limited | 128.58M | -1.29% | 89,789 | 762.00K |
| 340 | WHWK | Whitehawk Therapeutics, Inc. | 127.72M | -6.55% | 109,207 | 14.38M |
| 341 | MENS | Jyong Biotech Ltd. | 127.65M | -20.95% | 413,272 | - |
| 342 | STRO | Sutro Biopharma, Inc. | 124.38M | -1.95% | 68,126 | 105.65M |
| 343 | BDTX | Black Diamond Therapeutics, Inc. | 123.07M | -9.62% | 708,381 | 70.00M |
| 344 | MCRB | Seres Therapeutics, Inc. | 121.22M | -1.69% | 75,034 | 351.00K |
| 345 | FATE | Fate Therapeutics, Inc. | 121.12M | -8.70% | 1,748,593 | 7.14M |
| 346 | ADAG | Adagene Inc. | 119.71M | -10.56% | 43,051 | 103.20K |
| 347 | CDXS | Codexis, Inc. | 114.71M | -3.79% | 1,667,560 | 52.93M |
| 348 | ALXO | ALX Oncology Holdings Inc. | 111.69M | 2.49% | 2,493,652 | - |
| 349 | KPTI | Karyopharm Therapeutics Inc. | 111.51M | -3.33% | 607,612 | 142.53M |
| 350 | TTRX | Turn Therapeutics Inc. | 108.95M | -1.33% | 14,179 | - |
| 351 | KRRO | Korro Bio, Inc. | 108.68M | -5.87% | 151,790 | 7.37M |
| 352 | MGNX | MacroGenics, Inc. | 107.54M | -1.73% | 954,941 | 127.63M |
| 353 | INO | Inovio Pharmaceuticals, Inc. | 107.18M | -6.59% | 1,185,653 | 182.34K |
| 354 | VRCA | Verrica Pharmaceuticals Inc. | 105.69M | -7.42% | 245,329 | 30.83M |
| 355 | GNLX | Genelux Corporation | 104.07M | -8.91% | 303,689 | 8.00K |
| 356 | COYA | Coya Therapeutics, Inc. | 103.64M | -7.14% | 208,055 | 3.99M |
| 357 | ACTU | Actuate Therapeutics, Inc. | 100.41M | -8.67% | 77,802 | - |
| 358 | DWTX | Dogwood Therapeutics, Inc. | 100.26M | 1.46% | 60,819 | - |
| 359 | CRDF | Cardiff Oncology, Inc. | 99.69M | -6.33% | 964,319 | 501.00K |
| 360 | SEER | Seer, Inc. | 98.44M | -3.31% | 273,373 | 16.38M |
| 361 | VANI | Vivani Medical, Inc. | 98.22M | -6.82% | 342,543 | - |
| 362 | ACOG | Alpha Cognition Inc. | 97.84M | -10.36% | 36,070 | 7.43M |
| 363 | NBY | NovaBay Pharmaceuticals, Inc. | 96.65M | -20.86% | 1,687,766 | 10.30M |
| 364 | PYXS | Pyxis Oncology, Inc. | 95.89M | 1.99% | 801,392 | 2.82M |
| 365 | ARTV | Artiva Biotherapeutics, Inc. | 94.99M | -3.73% | 156,384 | 251.00K |
| 366 | AGEN | Agenus Inc. | 94.20M | -4.15% | 490,613 | 106.83M |
| 367 | ANIX | Anixa Biosciences, Inc. | 91.79M | -5.82% | 149,613 | - |
| 368 | SAVA | Cassava Sciences, Inc. | 91.30M | -3.08% | 784,409 | - |
| 369 | EXOZ | eXoZymes, Inc. | 91.14M | -3.04% | 2,508 | -700.00 |
| 370 | FBIO | Fortress Biotech, Inc. | 90.94M | -4.87% | 453,450 | 62.30M |
| 371 | CSBR | Champions Oncology, Inc. | 90.68M | -0.76% | 2,220 | 58.42M |
| 372 | EQ | Equillium, Inc. | 90.12M | -1.99% | 565,614 | 4.39M |
| 373 | ONCY | Oncolytics Biotech Inc. | 90.02M | -7.04% | 2,478,485 | - |
| 374 | CGTX | Cognition Therapeutics, Inc. | 88.25M | -2.94% | 1,063,068 | - |
| 375 | DTIL | Precision BioSciences, Inc. | 85.94M | -6.79% | 193,097 | 698.00K |
| 376 | BMEA | Biomea Fusion, Inc. | 80.60M | 4.59% | 2,752,375 | - |
| 377 | MNOV | MediciNova, Inc. | 79.62M | -0.61% | 79,554 | 257.92K |
| 378 | ATYR | aTyr Pharma, Inc. | 79.44M | -7.93% | 2,016,222 | 190.00K |
| 379 | OKYO | OKYO Pharma Limited | 77.05M | -3.06% | 91,489 | - |
| 380 | SPRB | Spruce Biosciences, Inc. | 75.84M | -10.58% | 32,674 | 697.00K |
| 381 | IMA | ImageneBio, Inc. | 74.77M | - | 44,475 | 800.00K |
| 382 | MAIA | MAIA Biotechnology, Inc. | 73.09M | -10.75% | 535,039 | - |
| 383 | PYPD | PolyPid Ltd. | 72.36M | -1.36% | 57,090 | - |
| 384 | PTHS | Pelthos Therapeutics Inc. | 71.98M | 0.05% | 7,966 | 7.41M |
| 385 | IMUX | Immunic, Inc. | 70.85M | -5.02% | 1,234,124 | - |
| 386 | XBIT | XBiotech Inc. | 70.12M | -4.56% | 78,982 | - |
| 387 | IBIO | iBio, Inc. | 69.96M | -2.27% | 970,909 | 500.00K |
| 388 | ATHE | Alterity Therapeutics Limited | 68.38M | 4.63% | 28,896 | 3.57M |
| 389 | PLRX | Pliant Therapeutics, Inc. | 66.98M | -7.23% | 1,269,424 | - |
| 390 | HYFT | MindWalk Holdings Corp. | 65.83M | -9.62% | 493,338 | 19.02M |
| 391 | ACET | Adicet Bio, Inc. | 65.08M | -13.32% | 277,736 | - |
| 392 | ANVS | Annovis Bio, Inc. | 64.67M | -5.43% | 345,612 | - |
| 393 | BYSI | BeyondSpring Inc. | 63.33M | -1.91% | 11,439 | 1.88M |
| 394 | GANX | Gain Therapeutics, Inc. | 62.31M | -7.95% | 930,973 | - |
| 395 | GUTS | Fractyl Health, Inc. | 61.35M | -5.99% | 11,272,264 | 3.00K |
| 396 | KZIA | Kazia Therapeutics Limited | 61.24M | -6.26% | 96,489 | 1.20M |
| 397 | COEP | Coeptis Therapeutics Holdings, Inc. | 60.27M | -19.68% | 150,093 | 501.00K |
| 398 | MREO | Mereo BioPharma Group plc | 59.67M | -8.54% | 3,746,210 | 500.00K |
| 399 | ETHZ | ETHZilla Corporation | 58.94M | -10.92% | 781,221 | 4.11M |
| 400 | TVGN | Tevogen Bio Holdings Inc. | 56.45M | -0.11% | 624,061 | - |
| 401 | IFRX | InflaRx N.V. | 55.92M | -1.74% | 684,731 | 73.73K |
| 402 | ESLA | Estrella Immunopharma, Inc. | 55.49M | 26.92% | 5,414,233 | - |
| 403 | LIMN | Liminatus Pharma, Inc. | 55.48M | 43.36% | 77,748,761 | - |
| 404 | ICCC | ImmuCell Corporation | 55.25M | 0.63% | 10,391 | 27.77M |
| 405 | RADX | Radiopharm Theranostics Limited | 54.48M | -0.82% | 100,232 | 8.20M |
| 406 | PMVP | PMV Pharmaceuticals, Inc. | 54.28M | -0.97% | 182,762 | - |
| 407 | GRCE | Grace Therapeutics, Inc. | 53.85M | -5.43% | 92,215 | - |
| 408 | ENTX | Entera Bio Ltd. | 53.65M | -2.50% | 228,773 | 124.00K |
| 409 | MGX | Metagenomi Therapeutics, Inc. | 52.94M | -2.76% | 592,273 | 30.91M |
| 410 | NTRB | Nutriband Inc. | 52.82M | 0.58% | 17,393 | 2.28M |
| 411 | INKT | MiNK Therapeutics, Inc. | 51.73M | -3.88% | 13,587 | - |
| 412 | TCRX | TScan Therapeutics, Inc. | 51.66M | -5.30% | 640,624 | 8.42M |
| 413 | IBO | Impact BioMedical Inc. | 50.87M | -0.78% | 54,650 | 25.00K |
| 414 | TIL | Instil Bio, Inc. | 50.59M | 0.54% | 147,183 | - |
| 415 | ACRV | Acrivon Therapeutics, Inc. | 50.49M | -5.33% | 599,589 | - |
| 416 | NRXP | NRx Pharmaceuticals, Inc. | 49.74M | -8.70% | 858,755 | 242.00K |
| 417 | QTTB | Q32 Bio Inc. | 47.62M | -3.73% | 197,400 | - |
| 418 | CING | Cingulate Inc. | 46.62M | 3.84% | 916,950 | - |
| 419 | NRXS | NeurAxis, Inc. | 46.34M | - | 33,310 | 3.36M |
| 420 | ATOS | Atossa Therapeutics, Inc. | 45.90M | 0.76% | 185,721 | - |
| 421 | OSTX | OS Therapies Incorporated | 44.72M | -4.51% | 633,607 | - |
| 422 | LONA | LeonaBio, Inc. | 44.63M | 1.27% | 62,645 | - |
| 423 | KZR | Kezar Life Sciences, Inc. | 44.16M | -0.49% | 26,856 | - |
| 424 | LPCN | Lipocine Inc. | 42.86M | -5.62% | 78,291 | 4.32M |
| 425 | CRVO | CervoMed Inc. | 42.56M | -1.50% | 83,398 | 6.16M |
| 426 | PSTV | Plus Therapeutics, Inc. | 41.38M | -3.39% | 5,051,034 | 5.26M |
| 427 | CVM | CEL-SCI Corporation | 41.20M | -2.20% | 82,419 | - |
| 428 | LSTA | Lisata Therapeutics, Inc. | 40.58M | -2.34% | 60,506 | 1.07M |
| 429 | ALGS | Aligos Therapeutics, Inc. | 39.94M | -8.20% | 61,177 | 2.65M |
| 430 | APLM | Apollomics, Inc. | 39.92M | -4.52% | 19,615 | 6.93M |
| 431 | NXTC | NextCure, Inc. | 38.84M | -6.26% | 11,072 | - |
| 432 | GBIO | Generation Bio Co. | 38.84M | 2.40% | 97,417 | 15.27M |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 38.51M | -3.45% | 300,629 | - |
| 434 | PDSB | PDS Biotechnology Corporation | 37.77M | -5.47% | 651,644 | - |
| 435 | INMB | INmune Bio Inc. | 37.75M | -6.58% | 213,302 | 50.00K |
| 436 | ABVC | ABVC BioPharma, Inc. | 37.71M | -15.79% | 183,742 | 797.92K |
| 437 | PLUR | Pluri Inc. | 36.42M | 10.61% | 54,620 | 1.33M |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 36.19M | - | 162,771 | 90.00K |
| 439 | GLTO | Galecto, Inc. | 36.15M | -4.84% | 50,437 | - |
| 440 | VERU | Veru Inc. | 35.95M | -11.46% | 166,280 | 16.89M |
| 441 | JSPR | Jasper Therapeutics, Inc. | 35.54M | -7.97% | 785,992 | - |
| 442 | XLO | Xilio Therapeutics, Inc. | 35.11M | -4.82% | 758,822 | 31.80M |
| 443 | LITS | Lite Strategy, Inc. | 34.97M | -10.27% | 511,504 | - |
| 444 | RNXT | RenovoRx, Inc. | 34.85M | -1.41% | 200,745 | 928.00K |
| 445 | ANEB | Anebulo Pharmaceuticals, Inc. | 33.94M | -13.06% | 42,307 | - |
| 446 | CELU | Celularity Inc. | 33.74M | -2.50% | 26,472 | 40.58M |
| 447 | TVRD | Tvardi Therapeutics, Inc. | 33.30M | -8.03% | 65,493 | - |
| 448 | ATRA | Atara Biotherapeutics, Inc. | 32.52M | -7.20% | 133,035 | 151.93M |
| 449 | OKUR | OnKure Therapeutics, Inc. | 31.43M | -3.33% | 157,951 | - |
| 450 | KYNB | Kyntra Bio, Inc. | 30.93M | -2.74% | 63,264 | 8.30M |
| 451 | DYAI | Dyadic International, Inc. | 30.04M | -2.03% | 14,896 | 3.34M |
| 452 | RNTX | Rein Therapeutics Inc. | 29.97M | -5.79% | 85,355 | - |
| 453 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 29.80M | -8.31% | 2,275,250 | - |
| 454 | BRNS | Barinthus Biotherapeutics plc | 29.42M | 2.93% | 7,622 | 14.97M |
| 455 | HOWL | Werewolf Therapeutics, Inc. | 29.42M | -5.56% | 177,186 | 1.14M |
| 456 | HYPD | Hyperion DeFi, Inc. | 29.06M | -5.21% | 311,078 | 345.32K |
| 457 | ANTX | AN2 Therapeutics, Inc. | 29.05M | - | 62,884 | - |
| 458 | PASG | Passage Bio, Inc. | 28.96M | -13.81% | 59,863 | - |
| 459 | CUE | Cue Biopharma, Inc. | 28.84M | 2.23% | 398,491 | 7.10M |
| 460 | NRSN | NeuroSense Therapeutics Ltd. | 28.81M | -3.12% | 98,124 | - |
| 461 | OTLK | Outlook Therapeutics, Inc. | 28.67M | -2.50% | 1,258,875 | 1.41M |
| 462 | LTRN | Lantern Pharma Inc. | 28.63M | -13.22% | 118,190 | - |
| 463 | PMN | ProMIS Neurosciences, Inc. | 28.20M | -16.29% | 64,164 | - |
| 464 | MRKR | Marker Therapeutics, Inc. | 27.68M | -8.79% | 226,485 | 4.69M |
| 465 | XCUR | Exicure, Inc. | 27.15M | 4.41% | 35,469 | 500.00K |
| 466 | HURA | TuHURA Biosciences, Inc. | 26.72M | -5.13% | 481,298 | - |
| 467 | SER | Serina Therapeutics, Inc. | 26.64M | -13.03% | 296,669 | 116.00K |
| 468 | LIXT | Lixte Biotechnology Holdings, Inc. | 26.31M | -6.21% | 69,141 | - |
| 469 | BCTX | BriaCell Therapeutics Corp. | 26.02M | -1.18% | 207,606 | - |
| 470 | AEON | AEON Biopharma, Inc. | 25.71M | -3.60% | 129,184 | - |
| 471 | SKYE | Skye Bioscience, Inc. | 25.63M | -8.11% | 341,752 | - |
| 472 | RLYB | Rallybio Corporation | 24.56M | 1.08% | 128,145 | 674.00K |
| 473 | BOLD | Boundless Bio, Inc. | 24.40M | 3.81% | 611,974 | - |
| 474 | EVAX | Evaxion A/S | 24.27M | -7.03% | 98,292 | 7.65M |
| 475 | PTN | Palatin Technologies, Inc. | 24.26M | 0.82% | 21,916 | 8.85M |
| 476 | DARE | Daré Bioscience, Inc. | 24.01M | -5.08% | 133,376 | -57.13K |
| 477 | IGC | IGC Pharma, Inc. | 23.80M | -3.72% | 568,086 | 1.11M |
| 478 | IOBT | IO Biotech, Inc. | 23.05M | 18.15% | 4,377,385 | - |
| 479 | SNTI | Senti Biosciences, Inc. | 21.62M | -8.65% | 304,883 | - |
| 480 | NEUP | Neuphoria Therapeutics Inc. | 21.48M | -0.12% | 42,498 | 15.65M |
| 481 | JUNS | Jupiter Neurosciences, Inc. | 21.20M | 12.60% | 221,149 | - |
| 482 | INTS | Intensity Therapeutics, Inc. | 20.35M | -1.83% | 842,013 | - |
| 483 | VTGN | Vistagen Therapeutics, Inc. | 19.95M | -4.03% | 958,333 | 721.00K |
| 484 | PLRZ | Polyrizon Ltd. | 19.81M | -7.03% | 78,655 | - |
| 485 | CASI | CASI Pharmaceuticals, Inc. | 19.52M | 0.80% | 12,670 | 26.85M |
| 486 | INAB | IN8bio, Inc. | 18.56M | -3.06% | 73,826 | - |
| 487 | VYNE | VYNE Therapeutics Inc. | 18.54M | -3.53% | 395,766 | 524.00K |
| 488 | NNVC | NanoViricides, Inc. | 18.33M | -5.56% | 258,292 | - |
| 489 | KTTA | Pasithea Therapeutics Corp. | 17.59M | -9.32% | 295,333 | - |
| 490 | GNTA | Genenta Science S.p.A. | 17.29M | -15.45% | 202,178 | - |
| 491 | LEXX | Lexaria Bioscience Corp. | 16.48M | -8.66% | 201,079 | 522.00K |
| 492 | KLTO | Klotho Neurosciences, Inc. | 16.23M | -13.11% | 1,301,251 | - |
| 493 | QNTM | Quantum BioPharma Ltd. | 15.20M | -2.00% | 80,564 | - |
| 494 | LNAI | Lunai Bioworks Inc. | 15.16M | -5.55% | 81,190 | - |
| 495 | FBLG | FibroBiologics, Inc. | 15.11M | -9.20% | 5,701,517 | - |
| 496 | ITRM | Iterum Therapeutics plc | 15.07M | -7.72% | 240,834 | 390.00K |
| 497 | CTXR | Citius Pharmaceuticals, Inc. | 14.78M | -7.70% | 1,713,045 | - |
| 498 | TRAW | Traws Pharma, Inc. | 13.74M | -11.34% | 275,605 | 2.85M |
| 499 | BLRX | BioLineRx Ltd. | 13.49M | -5.21% | 23,016 | 12.74M |
| 500 | GTBP | GT Biopharma, Inc. | 13.23M | -5.77% | 900,544 | - |
| 501 | OSRH | OSR Holdings, Inc. | 13.20M | -11.16% | 807,103 | -90.52K |
| 502 | BCDA | BioCardia, Inc. | 13.16M | 13.76% | 219,841 | 3.00K |
| 503 | ALLR | Allarity Therapeutics, Inc. | 13.03M | -3.85% | 202,080 | - |
| 504 | CVKD | Cadrenal Therapeutics, Inc. | 12.53M | -12.27% | 48,438 | - |
| 505 | GDTC | CytoMed Therapeutics Limited | 12.46M | 27.07% | 21,997,083 | 573.19K |
| 506 | KAPA | Kairos Pharma, Ltd. | 12.28M | -7.64% | 135,807 | - |
| 507 | BCAB | BioAtla, Inc. | 12.17M | -9.43% | 2,214,242 | 11.00M |
| 508 | MBRX | Moleculin Biotech, Inc. | 12.04M | -6.46% | 51,449 | - |
| 509 | NCEL | NewcelX Ltd. | 12.03M | -2.58% | 27,692 | - |
| 510 | CLRB | Cellectar Biosciences, Inc. | 11.96M | -5.69% | 37,248 | - |
| 511 | HOTH | Hoth Therapeutics, Inc. | 11.95M | -4.01% | 312,933 | - |
| 512 | COCP | Cocrystal Pharma, Inc. | 11.86M | -10.40% | 205,696 | - |
| 513 | CRIS | Curis, Inc. | 11.81M | -3.84% | 147,536 | 11.65M |
| 514 | KALA | KALA BIO, Inc. | 11.27M | -9.46% | 645,039 | - |
| 515 | SNSE | Sensei Biotherapeutics, Inc. | 11.23M | 1.71% | 60,755 | - |
| 516 | TPST | Tempest Therapeutics, Inc. | 10.99M | -6.30% | 156,963 | - |
| 517 | LGVN | Longeveron Inc. | 10.90M | -5.34% | 306,339 | 1.44M |
| 518 | GRDX | GridAI Technologies Corp. | 10.52M | 1.29% | 207,439 | - |
| 519 | SNGX | Soligenix, Inc. | 10.49M | -10.34% | 312,270 | 2.34K |
| 520 | IMNN | Imunon, Inc. | 10.44M | -1.60% | 47,020 | - |
| 521 | BOLT | Bolt Biotherapeutics, Inc. | 10.36M | -1.46% | 66,206 | 5.20M |
| 522 | AKTX | Akari Therapeutics, Plc | 10.19M | -2.22% | 272,148 | - |
| 523 | CLGN | CollPlant Biotechnologies Ltd. | 9.58M | -53.42% | 864,498 | 2.48M |
| 524 | EDSA | Edesa Biotech, Inc. | 9.33M | 2.75% | 41,038 | - |
| 525 | PHIO | Phio Pharmaceuticals Corp. | 9.22M | -7.37% | 423,239 | - |
| 526 | EVGN | Evogene Ltd. | 9.16M | 0.92% | 580,799 | 8.02M |
| 527 | RNAZ | TransCode Therapeutics, Inc. | 9.14M | 16.20% | 11,708,870 | - |
| 528 | PULM | Pulmatrix, Inc. | 9.09M | -3.08% | 8,762 | 3.00K |
| 529 | BRTX | BioRestorative Therapies, Inc. | 9.05M | -0.97% | 19,192 | 383.40K |
| 530 | CMMB | Chemomab Therapeutics Ltd. | 8.92M | -11.04% | 87,957 | - |
| 531 | CALC | CalciMedica, Inc. | 8.80M | -7.44% | 899,846 | - |
| 532 | NCNA | NuCana plc | 8.70M | -12.18% | 81,858 | - |
| 533 | ICU | SeaStar Medical Holding Corporation | 8.69M | -6.23% | 44,548 | 881.00K |
| 534 | XTLB | XTL Biopharmaceuticals Ltd. | 8.56M | -0.93% | 64,920 | 968.00K |
| 535 | QNCX | Quince Therapeutics, Inc. | 8.14M | -8.06% | 3,981,312 | - |
| 536 | BIVI | BioVie Inc. | 7.99M | -8.62% | 146,127 | - |
| 537 | KPRX | Kiora Pharmaceuticals, Inc. | 7.78M | -3.20% | 79,400 | 20.00K |
| 538 | ADXN | Addex Therapeutics Ltd | 7.65M | 0.39% | 2,826 | 198.82K |
| 539 | IMRN | Immuron Limited | 7.28M | -4.00% | 12,885 | 4.78M |
| 540 | PHGE | BiomX Inc. | 7.27M | -13.80% | 88,202 | - |
| 541 | TOVX | Theriva Biologics, Inc. | 7.13M | 14.23% | 5,270,950 | - |
| 542 | ALZN | Alzamend Neuro, Inc. | 7.11M | -10.10% | 107,891 | - |
| 543 | PMCB | PharmaCyte Biotech, Inc. | 7.09M | -1.02% | 117,990 | - |
| 544 | REVB | Revelation Biosciences, Inc. | 6.98M | -7.55% | 376,880 | - |
| 545 | VIVS | VivoSim Labs, Inc. | 6.75M | 10.21% | 299,306 | 140.00K |
| 546 | CELZ | Creative Medical Technology Holdings, Inc. | 6.64M | -3.55% | 29,880 | 6.00K |
| 547 | PPBT | Purple Biotech Ltd | 6.60M | -0.43% | 179,963 | - |
| 548 | QNRX | Quoin Pharmaceuticals, Ltd. | 6.56M | 6.11% | 26,368 | - |
| 549 | CLDI | Calidi Biotherapeutics, Inc. | 6.16M | -11.79% | 112,926 | - |
| 550 | APM | Aptorum Group Limited | 6.03M | -10.80% | 82,369 | - |
| 551 | APVO | Aptevo Therapeutics Inc. | 6.00M | -6.24% | 86,954 | - |
| 552 | CANF | Can-Fite BioPharma Ltd. | 5.96M | 5.20% | 524,284 | 560.00K |
| 553 | MTVA | MetaVia Inc. | 5.55M | -6.99% | 187,571 | - |
| 554 | ERNA | Ernexa Therapeutics Inc. | 5.34M | -19.76% | 158,667 | 1,000.00 |
| 555 | TCRT | Alaunos Therapeutics, Inc. | 5.22M | -3.27% | 17,048 | 6.00K |
| 556 | MBIO | Mustang Bio, Inc. | 5.20M | 1.16% | 6,802,109 | - |
| 557 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.96M | -12.10% | 140,943 | 1.36M |
| 558 | PCSA | Processa Pharmaceuticals, Inc. | 4.92M | -8.82% | 74,075 | - |
| 559 | ACXP | Acurx Pharmaceuticals, Inc. | 4.84M | -1.90% | 64,017 | - |
| 560 | XBIO | Xenetic Biosciences, Inc. | 4.77M | -4.59% | 28,135 | 2.86M |
| 561 | SLXN | Silexion Therapeutics Corp | 4.72M | -12.72% | 42,328 | - |
| 562 | GNPX | Genprex, Inc. | 4.55M | -11.31% | 453,450 | - |
| 563 | GOVX | GeoVax Labs, Inc. | 4.43M | -8.51% | 82,929 | 3.35M |
| 564 | APRE | Aprea Therapeutics, Inc. | 4.37M | -6.81% | 407,903 | 488.24K |
| 565 | DRMA | Dermata Therapeutics, Inc. | 4.22M | -8.29% | 268,486 | - |
| 566 | MLEC | Moolec Science SA | 4.18M | 7.48% | 44,391 | 7.83M |
| 567 | CYCN | Cyclerion Therapeutics, Inc. | 4.11M | -12.90% | 134,630 | 2.86M |
| 568 | ABP | Abpro Holdings, Inc. | 4.07M | -19.35% | 64,092 | 183.00K |
| 569 | BGMS | Bio Green Med Solution, Inc. | 4.07M | -14.43% | 177,875 | 81.00K |
| 570 | DCOY | Decoy Therapeutics Inc. | 3.96M | -1.59% | 256,777 | - |
| 571 | SILO | Silo Pharma, Inc. | 3.82M | -7.69% | 158,701 | 72.10K |
| 572 | ADIL | Adial Pharmaceuticals, Inc. | 3.81M | -12.63% | 1,288,166 | - |
| 573 | MTNB | Matinas BioPharma Holdings, Inc. | 3.66M | -9.55% | 143,974 | - |
| 574 | ENVB | Enveric Biosciences, Inc. | 3.66M | -7.39% | 46,434 | - |
| 575 | ASBP | Aspire Biopharma Holdings, Inc. | 3.55M | -14.84% | 403,079 | 1.94K |
| 576 | INDP | Indaptus Therapeutics, Inc. | 3.48M | -13.41% | 39,638 | - |
| 577 | XRTX | XORTX Therapeutics Inc. | 3.46M | -17.71% | 2,526,708 | - |
| 578 | GLMD | Galmed Pharmaceuticals Ltd. | 3.26M | -6.30% | 39,217 | - |
| 579 | GRI | GRI Bio, Inc. | 3.16M | -17.05% | 160,475 | - |
| 580 | LYRA | Lyra Therapeutics, Inc. | 3.14M | -6.10% | 16,325 | 600.00K |
| 581 | PBM | Psyence Biomedical Ltd. | 2.95M | -10.80% | 141,531 | - |
| 582 | SCNI | Scinai Immunotherapeutics Ltd. | 2.94M | -6.93% | 4,504 | 1.15M |
| 583 | CNSP | CNS Pharmaceuticals, Inc. | 2.82M | -12.67% | 29,384 | - |
| 584 | OGEN | Oragenics, Inc. | 2.77M | -13.53% | 115,086 | - |
| 585 | ARTL | Artelo Biosciences, Inc. | 2.77M | -5.52% | 48,023 | - |
| 586 | PPCB | Propanc Biopharma, Inc. | 2.70M | 5.71% | 42,330,119 | - |
| 587 | JAGX | Jaguar Health, Inc. | 2.69M | 2.12% | 421,900 | 11.79M |
| 588 | HCWB | HCW Biologics Inc. | 2.67M | -5.71% | 123,466 | 422.03K |
| 589 | SPRC | SciSparc Ltd. | 2.66M | -7.54% | 119,131 | 1.31M |
| 590 | BBLG | Bone Biologics Corporation | 2.45M | -11.36% | 36,166 | - |
| 591 | AZTR | Azitra, Inc. | 2.25M | -8.91% | 3,548,437 | 7.50K |
| 592 | CMND | Clearmind Medicine Inc. | 2.17M | -17.61% | 104,397 | - |
| 593 | CDIO | Cardio Diagnostics Holdings, Inc. | 1.92M | -13.93% | 144,923 | 15.78K |
| 594 | ELAB | PMGC Holdings Inc. | 1.90M | -20.40% | 480,530 | 285.95K |
| 595 | ONCO | Onconetix, Inc. | 1.90M | -9.63% | 95,910 | 1.22M |
| 596 | CDT | CDT Equity Inc. | 1.86M | -4.72% | 247,141 | - |
| 597 | ENSC | Ensysce Biosciences, Inc. | 1.67M | -19.35% | 293,457 | 4.49M |
| 598 | VRAX | Virax Biolabs Group Limited | 1.65M | -10.24% | 169,218 | 2.99K |
| 599 | ADTX | Aditxt, Inc. | 1.11M | -5.66% | 107,936 | 5.95K |
| 600 | BDRX | Biodexa Pharmaceuticals Plc | 1.09M | -10.34% | 253,358 | 104.90K |